Legal & General Group’s Foundation Medicine, Inc. FMI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-5,408
| Closed | -$740K | – | 3414 |
|
|
2018
Q2 | $740K | Sell |
5,408
-325
| -6% | -$29.5K | ﹤0.01% | 2011 |
|
|
2018
Q1 | $451K | Buy |
5,733
+2,019
| +54% | +$149K | ﹤0.01% | 2132 |
|
|
2017
Q4 | $254K | Sell |
3,714
-101
| -3% | -$5.24K | ﹤0.01% | 2248 |
|
|
2017
Q3 | $154K | Buy |
3,815
+373
| +11% | +$14.4K | ﹤0.01% | 2432 |
|
|
2017
Q2 | $138K | Buy |
3,442
+274
| +9% | +$10K | ﹤0.01% | 2447 |
|
|
2017
Q1 | $102K | Sell |
3,168
-101
| -3% | -$2.52K | ﹤0.01% | 2529 |
|
|
2016
Q4 | $58K | Buy |
3,269
+1,042
| +47% | +$22.5K | ﹤0.01% | 2846 |
|
|
2016
Q3 | $51K | Hold |
2,227
| – | – | ﹤0.01% | 2516 |
|
|
2016
Q2 | $40K | Hold |
2,227
| – | – | ﹤0.01% | 2588 |
|
|
2016
Q1 | $39K | Hold |
2,227
| – | – | ﹤0.01% | 2520 |
|
|
2015
Q4 | $47K | Hold |
2,227
| – | – | ﹤0.01% | 2492 |
|
|
2015
Q3 | $41K | Hold |
2,227
| – | – | ﹤0.01% | 2554 |
|
|
2015
Q2 | $73K | Sell |
2,227
-502
| -18% | -$20.2K | ﹤0.01% | 2346 |
|
|
2015
Q1 | $132K | Hold |
2,729
| – | – | ﹤0.01% | 1869 |
|
|
2014
Q4 | $62K | Hold |
2,729
| – | – | ﹤0.01% | 2306 |
|
|
2014
Q3 | $52K | Buy |
+2,729
| New | +$65.1K | ﹤0.01% | 2365 |
|
Legal & General Group's FMI Position: Q3 2018 in Review
Legal & General Group sold out of Foundation Medicine, Inc. (FMI) in Q3 2018, closing a stake of 5,408 shares — an estimated $740K sold.
Legal & General Group first reported a position in FMI in Q3 2014 and held it in 16 quarters. The position peaked at $740K in Q2 2018. 0 funds tracked by Wall St. Rank hold FMI as of Q3 2018.
- Legal & General Group reported no remaining Foundation Medicine, Inc. position as of Q3 2018 after selling out during the quarter.
- Legal & General Group sold 5,408 Foundation Medicine, Inc. shares in Q3 2018, an estimated $740K.
- Legal & General Group first reported a position in Foundation Medicine, Inc. in Q3 2014 and held it in 16 quarters.
- Legal & General Group's Foundation Medicine, Inc. position peaked at $740K in Q2 2018.
- 0 funds tracked by Wall St. Rank held Foundation Medicine, Inc. as of Q3 2018.
Based on Legal & General Group's 13F filing for Q3 2018, filed 20 Nov 2018.